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After many years of decline, tuberculosis (TB)
cases began to resurge in the United States in
1984, and continued to climb for a decade before
declining again (1-4). Reemergent TB did not
affect all segments of the population equally.
While incidence continued to decline in some
geographic areas, it increased in others, notably
in the greater New York City area, southern
Florida, the border areas of Texas, and urban
California. Disadvantaged populations were
disproportionately affected, with peak incidences
in blacks and Hispanics now seen in young adults.
TB in foreign-born persons accounts for nearly 40%
of the total annual cases in the United States (5).
Finally, HIV infection has played a large part in
the recent increase in TB incidence. Effective
TB control requires reliable estimates of future
secular trends. We have constructed a population
dynamics, mechanistic Markov chain model for
the epidemiology of TB in the United States by
separate modeling for disaggregated groups
defined by race, ethnicity, age, and geography.
With this model, we have projected TB incidence
for the U.S. population at large, as well as for
racial and ethnic and geographically defined
groups within the population.
The Study
In support of this work, we obtained datasets
from the U.S. Bureau of the Census and the
Centers for Disease Control and Prevention (6-19).
The epidemiology of TB in the United States
has an underlying Markovian nature (20-22).
Except in unknown or difficult-to-predict influxes
of immigrants, future infections and cases of TB
may be probabilistically estimated by knowing
sufficiently well the present situation of
susceptible, infected, and ill persons; rates of
transition from healthy to infected and infected to
ill; patterns of contact; and rates of fertility and
death. Indeed, a Markov chain is completely
specified by an initial state and transition
probabilities. To model the future course of TB in
the United States, we used the structure depicted
in Figure 1.
The U.S. population was disaggregated into
states multivariately defined by sociodemographic,
health, and disease descriptors: age (single-year
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Figure 1. Tuberculosis model states and possible
transitions. Thicker lines depict transitions consid-
ered in sensitivity analysis.
age groups); sex; race (white, black, Asian or
Pacific islander, Native American or Alaskan
native, or other race); ethnicity (Hispanic or non-
Hispanic); TB infection or disease status; and
location. One hundred sixty locations were
defined: 60 corresponded to the largest standard
metropolitan statistical areas (SMSAs) in the
United States, 50 to groupings of smaller SMSAs
in the 50 states, and 50 to groupings of non-SMSA
counties in the 50 states. The impact of the HIV
epidemic on the TB epidemic was addressed by
dealing with certain location-specific populations
in a way that recognizes that a fraction of them
are dually affected. A state in the Markov chain
was completely defined by the joint specification
of all these descriptors.
In the absence of longitudinal data, the
population database for the model was con-
structed by assembling population profiles for
each of the individual years from historical
surveys and population projections (5-17,23).
These profiles consisted of the sizes of population
groups defined multivariately by age, race, sex,
ethnicity, and geographic location. The popula-
tion projections of the Bureau of the Census
incorporate expected immigration patterns.
Transition probabilities for the model were
based on rates cited in the literature to describe
how these transitions occur for individuals. The
probability of transition from healthy to infected
has been termed the “annual risk for infection.”
To estimate this probability from tuberculin skin
test surveys, we used the catalytic method of
Muench (19,24,25). This method relates inci-
dence to prevalence, given several data points of
the latter, under the assumption of an
exponential model, the exponential curve being
called “catalytic” at the time of Muench, who used
graphic methods for estimation. The average
number of susceptible persons infected by each
infectious (i.e., sputum-positive) case in a
geographic location in 1 year was termed the
“contagious parameter” by Styblo, who noted the
correspondence between the prevalence rate of
the disease and the annual risk for infection
(25,26). Since we assume that new active cases
are treated during their year of occurrence, our
use of the contagious parameter is consistent
with that of Styblo.
An important assumption made in the model
about the spread of infection is that each ill
person infects susceptible persons entirely within
race ethnicity location-specific subgroups, with
the number of infections determined by the
contagious parameter. The age-sex distribution
of newly infected persons in the model was based
on national TB contact investigation data (27).
Time trends for contagious parameters for the
various race ethnicity location-specific subgroups
were based on quadratic regression fits of the
total cases of TB for those subgroups over time
from 1980 through 1993. For illustration, we
present in Table 1 baseline values for the
contagious parameter for 17- to 25-year-old white
men, by state, derived from the U.S. naval
recruits data (28-35).
The probability of transition from infected to
ill is a product of host-parasite interactions and is
determined by the biologic features of these
interactions. A person with a new Mycobacterium
tuberculosis infection (i.e., an infection of <1 year)
is at much higher risk for clinical disease than
someone with a mature infection, who has been at
an ongoing risk in later years (36). These risks
vary with age. Although not explicitly modeled,
reinfection of cured persons is allowed at the
same rate as infections with the same150 Emerging Infectious Diseases Vol. 6, No. 2, March–April 2000
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Table 1. Baseline values of contagious parameters, for 17-
to 25-year-old white men, by state
New ACRa ARIb ARI/TBc
Alabama 0.13 38.2 293.6
Arizona 0.30 52.7 178.3
Arkansas 0.15 39.7 261.6
California 0.16 36.4 228.1
Colorado 0.19 18.9   97.4
Connecticut 0.12 15.7 134.2
Delaware 0.12 30.1 243.2
District of Columbia 0.15 55.6 376.1
Florida 0.07 27.4 410.5
Georgia 0.08 31.8 395.7
Idaho 0.10 13.2 135.3
Illinois 0.15 39.6 269.3
Indiana 0.16 30.7 198.0
Iowa 0.07   9.2 130.4
Kansas 0.07 12.6 176.9
Kentucky 0.28 50.6 177.9
Louisiana 0.10 35.4 339.6
Maine 0.14 25.2 179.9
Maryland 0.22 36.4 164.4
Massachusetts 0.14 28.9 203.9
Michigan 0.14 29.7 205.3
Minnesota 0.10 17.3 181.8
Mississippi 0.09 30.3 334.3
Missouri 0.14 32.9 231.8
Montana 0.11 13.6 123.2
Nebraska 0.09 16.4 174.5
Nevada 0.07 53.8 747.9
New Hampshire 0.11 16.8 153.6
New Jersey 0.15 23.7 161.6
New Mexico 0.22 29.1 130.9
New York 0.17 36.6 218.1
North Carolina 0.08 26.1 342.8
North Dakota 0.07   8.6 122.5
Ohio 0.14 27.1 198.2
Oklahoma 0.13 24.0 185.8
Oregon 0.12 32.0 257.0
Pennsylvania 0.17 32.1 183.8
Rhode Island 0.12 27.9 235.7
South Carolina 0.04 26.7 615.2
South Dakota 0.06   9.2 163.8
Tennessee 0.19 45.8 244.7
Texas 0.21 29.2 138.7
Utah 0.04   7.6 197.1
Vermont 0.18 18.3   99.3
Virginia 0.13 32.1 237.9
Washington 0.11 25.7 231.9
West Virginia 0.21 39.1 189.4
Wisconsin 0.08 22.1 260.1
Wyoming 0.15 10.3   66.7
Total 0.14 30.1 210.3
aACR, Active case rate per 100,000 per year tuberculosis
bARI, Annual rate of infection per 100,000 per year
cContagious parameter
characteristics in the population. The case rates
among persons with new and mature infections in
the next year are based on the upper and lower
bounds of rates reported in earlier studies, and
are adjusted to calibrate the model to the
historical time series (27,37-42) (Table 2).
The effects of the HIV epidemic and the
emergence of multidrug-resistant TB are mod-
eled through time-dependent exogenous inputs
for appropriate geographic locations and, within
these locations, for specific demographic sub-
groups, as dictated by trends in prevalence and
dual-infection rates (43-45). These calculations
result in time-dependent changes to the
probabilities of transition from new or mature
infection to clinical TB.
We established 1980 as the baseline year for
all variables used in the model. The initial values
of these variables were based on the Reports of
Verified Cases of Tuberculosis (RVCT) files and
published reports of TB incidence from Centers
for Disease Control and Prevention. Because the
RVCT program was not implemented nationwide
until 1985, reporting for the years 1980 to 1984
was incomplete. To estimate the 1980 baseline
values, we inferred values of missing data
according to the multivariate structure observed
in 1985. Baseline information also included
counts of mature infections prevalent in 1980 and
counts of new infections in 1980. These values
were estimated by applying difference equations
relating the numbers of cases, new infections, and
mature infections in a given year to the numbers
new infections, and mature infections in the
previous year, where the relationships between
the figures for the 2 years were dependent on
model parameters such as survival rates, rates of
transition from mature infection to disease, rates
of transition from new infection to disease, and
contagious parameters, and where each differ-
ence equation pertained to a specific multivariately
defined subpopulation. Through repeated appli-
cation of the difference equations, it was possible
to express the number of mature infections in
1980 in terms of TB case counts for an arbitrary
number of subsequent years for which actual data
were available. Estimates thus obtained were
examined for consistency and the most stable was
selected. Because of the lack of reliable
information, we did not attempt to address the
underreporting of TB cases or underestimates of
some populations.151 Vol. 6, No. 2, March–April 2000 Emerging Infectious Diseases
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Table 2. Literature-based lower, best, and upper estimates of the risk of developing tuberculosis for infected persons, by
age and sex
Acute risk Ongoing risk
Age Male Female Male Female
<1 0.013, 0.07, 0.07 0.013, 0.07, 0.07 0.0016, 0.004, 0.009 0.0016, 0.004, 0.009
    1-4 0.013, 0.026, 0.026 0.013, 0.026, 0.026 0.0016,  0.004, 0.009 0.0016, 0.004, 0.009
    5-14 0.002, 0.002, 0.006 0.002, 0.002, 0.006 0.0008, 0. 0008, 0.0013 0.0008, 0.0008, 0.0013
15-34 0.002, 0.01, 0.01 0.002, 0.02, 0.02 0.0003, 0.0013, 0.0042 0.0003, 0.0016, 0.005
35-54 0.0014, 0.009, 0.009 0.0014, 0.009, 0.009 0.0002, 0.0009, 0.0015 0.0002, 0.0009, 0.0015
55+ 0.0019, 0.005, 0.005 0.0019, 0.005, 0.005 0.001, 0.001, 0.002 0.001, 0.001, 0.002
Figure 2. Total number of new cases of tuberculosis in
white non-Hispanics, blacks, and Hispanics in the
United States, 1980–2010.
Computer implementation of the model was
carried out on a Sun SPARCstation 5 with 80
megabytes of main memory and network access
to a SPARCserver 1000E with approximately 100
gigabytes of online disk storage. All software was
written in C++, an object-oriented programming
language. A library of C++ objects and functions
(46,47) was used as the basis for the
representation of fuzzy numbers in the software.
Because of the extremely large sizes of the
multidimensional arrays containing cross-sec-
tional population data and year-to-year transi-
tion data, specialized data structures and
algorithms were developed to take advantage of
characteristics of these data that allowed them to
be stored in a more compact form (48). For cross-
sectional population data, a height-balanced
binary search tree structure (49,50) was used.
Within each tree node, both cell information and
array subscript information were stored. Because
the subscripts would occupy at least 9 bytes
within each node of the tree if stored
conventionally, a 4-byte compressed representa-
tion of the subscripts was stored within each
node. For transition data, a simple linked-list
structure was used in which each node contained
both cell information and compressed subscript
information. This approach resulted in a 96%
reduction of storage space required for population
data and a 99% reduction of storage space
required for transition data (48).
Results
Figure 2 presents model projections of new
cases of TB for the United States for 1980 through
2010 as well as actual data for white non-
Hispanics, blacks, and Hispanics, the groupings
used in TB case reporting in the United States.
For these three groups, differences between
actual counts and model predictions were
generally <1,000 for blacks and Hispanics and
<1,500 for white non-Hispanics.
Table 3 presents actual and projected TB case
rates per 100,000 for each 5 years from 1980 to
2010 with results presented for racial, ethnic, and
geographic groups. Generally, the model per-
forms best, within the 1980 to 1995 validation
period, for large subgroups with relatively high
case rates. For example, it projects TB case rates
to within 12% of actual rates for the U.S.
population at large. Its performance is not as good
in subgroups having lower case rates (e.g., there
is a 23% projection error for non-Hispanic whites
in 1995). In addition, projection errors are
relatively high for smaller subgroups, especially
those in which case reporting and population
reporting are subject to inaccuracy (e.g.,
projection errors are consistently above 20% for
Hispanics and nearly as high for American
Indians and Asian/Pacific Islanders). The model’s
best performance tends to be among the older
population: the model predicts case rates to152 Emerging Infectious Diseases Vol. 6, No. 2, March–April 2000
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Table 3. Actual and projected tuberculosis rates per 100,000 for selected population groups, 1980 to 2010
Year
1980 1985 1990 1995 2000 2005 2010
Actual Proj. Actual Proj. Actual Proj. Actual Proj. Proj. Proj.
All (12.5) 10.6   (9.5) 11.3 (10.4)   9.7   (8.7)   8.3   6.6   4.6
By race/ethnicity
White,  not  Hispanic   (6.6)   5.1   (4.7)   4.8   (4.2 )   3.8   (3.1)   3.2   2.6   2.1
Black, not Hispanic (34.3) 30.5 (28.0) 34.7 (33.0) 27.9 (23.9) 23.1 16.9   9.3
Hispanic (25.6) 24.1 (18.2) 26.5 (22.1) 33.2 (18.0) 28.5 23.2 16.7
American Indian (32.7) 31.5 (24.5) 26.3 (19.5) 19.2 (16.5) 16.6 11.4   7.0
Asian/Pacific Islander (86.4) 39.9 (50.9) 34.9 (42.8) 27.1 (45.9) 20.1 13.1   6.2
By age
Under  5   (1.1)   3.6   (4.4)   4.3   (5.1)   4.1   (4.7)   3.5   3.2   2.4
 5-14   (0.8)   2.5   (1.4)   2.4   (1.9)   2.2   (1.7)   1.9   1.7   1.3
15-24   (2.8)   6.0   (4.3)   8.1   (5.2)   6.9   (4.7)   5.8   4.3   3.0
25-44   (8.4) 10.6   (9.4) 12.5 (12.0) 10.7   (9.9)   9.3   7.3   4.4
45-64 (19.6) 14.0 (14.0) 15.3 (13.7) 13.6 (11.5) 11.7   8.9   5.9
65+ (49.9) 27.1 (24.8) 20.1 (20.3) 16.1 (16.0) 13.4 11.1   8.5
Selected Metropolitan
Areas
New York City (18.6) 24.9 (24.7) 41.7 (43.9) 35.2 (30.1) 30.3 25.3 17.9
San Francisco (19.8) 13.8 (16.7) 17.9 (21.9) 18.3 (23.0) 17.4 13.2   5.1
Los Angeles (24.8) 26.7 (19.2) 30.5 (23.6) 31.5 (19.1) 27.7 22.1 15.6
Miami (28.0) 17.5 (23.7) 21.1 (23.6) 13.3 (19.1)   9.9   8.8   5.7
Figure 3. Projected quartiles of tuberculosis case rates
per 100,000 by state, 2010.
Figure 4. Total number of new cases of tuberculosis in
the United States, 1980–2010 and sensitivity of model
projections.
within 1% accuracy for the U.S. population aged
65 and over for 1990 and 1995. This is of
significance in that the highest TB case rates are
among the elderly.
Figure 3 presents model projections of the TB
case rate quartiles, by state, for the year 2010.
Note that the projected case rate for Wyoming
spuriously falls into the highest quartile, as a
result of its small population size. TB is projected
to decrease in all parts of the United States and
remain largely a problem of states receiving large
numbers of immigrants.
In Figure 4, the model projection for the
United States for 1980 through 2010 is presented
together with actual numbers of newly reported
TB cases for 1980 through 1997. Also depicted is
the sensitivity of the model to changes in key
parameters, seen in thicker lines in Figure 1.
Specifically, changes were allowed for the
contagious parameters and for rates of transition
from healthy to infected and infected to ill.153 Vol. 6, No. 2, March–April 2000 Emerging Infectious Diseases
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Specifically, above and below the central
projection are lines representing projections from
simultaneous 10% increases and decreases in
these key parameters for each year in the
projection period. A simultaneous decrease of
10% in the parameters for each year of the
projection period results in a decrease of 27%
(from 13,458 to 9,861) in projected TB cases in
2010. A simultaneous increase of 10% yields an
increase of 44% (from 13,458 to 19,381) in
projected cases in 2010. Not shown in the figure,
a simultaneous decrease of 5% in the same
parameters yields a decrease of 15% (from 13,458
to 11,459) for projected cases in 2010, and a
simultaneous increase of 5% yields an increase of
19% (from 13,458 to 16,063) in 2010.
Conclusions
The studies of Waaler and colleagues, who
carefully noted and credited other early workers
in this field, mark the beginning of a modern
approach to modeling and the thoughtful
consideration of transition probabilities in
modeling (51,52). ReVelle, Lynn, and Feldman,
using many of the assumptions of Waaler and his
colleagues, projected declining TB case rates in
developing countries as a result of BCG
vaccination (53). Azuma modeled TB incidence in
Japan (54). Estimates of AIDS prevalence were
used by Styblo (55), Schulzer and colleagues (56),
and Heymann (57) to project TB incidence in sub-
Saharan Africa. Modeling was used by Murray,
Styblo, and Rouillon to examine the economic
impact of TB in developing countries (58). Blower
and colleagues used a differential equation-based
model to examine the decline of TB epidemics and
emphasize the importance of effective case
treatment in TB control (59,60). Murray and
colleagues used differential equation-based
models to compare the global impact of different
control strategies (61,62). Brewer and colleagues
used simulation techniques to compare TB
control policies (63).
Mathematical modeling of TB in the United
States probably began in 1939 with the early work
of Frost, who used age cohort analyses of secular
trends to predict the future decline of TB (64).
Ferebee developed a model for TB in the United
States based on data from 1963 and used it to
emphasize the potentially important contribution
of chemoprophylaxis to TB control (65). The
model we present is substantially more complex
than Ferebee’s and differs from her early work by
disaggregating the American population. Given
the marked heterogeneity of the population of the
United States and the corresponding diversity of
TB case rates in various American population
groups, our approach offers major advantages
over aggregate modeling both in improved
accuracy of estimation of input data and in output
that can be disaggregated to relate to segments of
the population with very different TB control
problems.
A highly disaggregated model incorporating
population dynamics is appropriate. When
applied to small groups, population dynamics are
aptly described by a linear model, particularly
when natural constraints are stated as totals. The
model we constructed is Markovian in that it is
independent of its history prior to its last known
state.  Our computer implementation of the
theoretical model is clearly Markovian because
its operation parallels the nature of a Markov
chain, in the sense that the initial state was the
state of our system in 1980, and the state in each
subsequent year was generated from the previous
year’s state and 1-year transition rates. Since no
information other than the previous year’s state
and 1-year transition rates are available to the
computer software to generate the state for a
year, the Markovian nature is established.
Our model for the intermediate years
predicted (on the basis of 1980 baseline data) that
TB would increase late in the ensuing decade and
decline again. This prediction reasonably
approximated the subsequent events. While the
model does include changes in TB incidence
related to the HIV epidemic and to immigration,
it does not specifically incorporate changes in TB
control measures, whose impacts are only
addressed indirectly through net changes of
transition probabilities in the model. The latter
could be addressed by a submodel for appropriate
population subgroups, and could affect projections.
The projections presented here suggest that
the number of new cases and incidence rates of
TB will now continue to decrease to a level
approximately half the present level nationally.
Measuring the extent to which increased control
efforts contributed to the return of the TB
epidemic to its formerly declining phase will
require more detailed analysis.
The handling of geographic location necessar-
ily relies on politically defined entities which
determine how data are collected. Since disease
patterns do not necessarily follow these154 Emerging Infectious Diseases Vol. 6, No. 2, March–April 2000
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boundaries, the model is not uniformly accurate
by geographic location. This may be seen in Table
3 where the TB case rate in 1995 is overestimated
for Los Angeles and underestimated for Miami.
However, the very fine age structure imposed has
resulted in projections by age group within 20%
accuracy for age 25 and older (Table 3).
Refinement of the geographic characterization
could result in corresponding increases in accuracy.
The model projections are smoother over time
than the actual counts, as should be expected
because random fluctuations are not built into the
model (Figures 2,3). In Figure 4 the time series of
actual cases is moving toward the lower 10%
bound. This may be a temporary fluctuation (as in
the mid-1980s) but could also indicate changes in
transitions in the real-world disease process.
Errors of a projection model may arise from
shortcomings of model structure, from inaccura-
cies in initial conditions, or from errors in the
values of key model parameters. The structure of
the Markov chain model is mechanistic, driven by
highly detailed population dynamics. Each part
of the mechanistic process may prompt sugges-
tions for model refinements and discussions of
variability; notably, occurrence of infection
(66,67), time from infection to disease (68,69),
and involvement of HIV (70) and immigrant
status (71). The greatest potential for model
inaccuracy due to initial conditions arises from
estimates of the 1980 pool of prevalent infections.
Errors thus introduced become less consequential
with passing time, as persons infected before
1980 die. So, model projections in the latter part
of the projection period are least affected by
errors in the numbers of those infected before
1980. Model parameters not only have the
obvious role of governing transitions for various
population subgroups, but also, as reflected by
their time dependency, are used to depict
exogenous phenomena such as the HIV epidemic,
implementation of TB control efforts, and
changes in immigration patterns. Geographically
focused changes of TB control efforts imple-
mented after 1993 related to directly observed
therapy could result in overestimation in
projections in those areas.
Although the model does not allow mixing of
groups from one location to another, this
limitation is in large measure adjusted in the
calculations of transition probabilities since these
are based on actual data that implicitly reflect the
movements of healthy, infected, and ill groups.
The other type of mixing not accounted for in the
model occurs in a location among different race-
ethnicity subgroups. The most serious projection
errors would then occur when a subgroup of
uninfected persons lives in the same location as a
subgroup of persons with active TB, for then any
cases arising in the former subgroup would not be
predicted by our model. This type of situation is
likely to arise only in locations with very few
active TB cases. Otherwise, the projection errors
arise only from the extent to which the cross-
spread of infection fails to cancel out (i.e., the net
extent to which a subgroup infects others, over
and above the number of the latter being infected
by the former).
Although HIV status is addressed in this
model, adding structure that more precisely
reflects changes in transition rates of HIV-
infected persons might also improve model
projections. The model predicts that an
increasing portion of cases will occur in
Hispanics, and this prediction is supported by the
most recent data, which show that the rate of
decline in the number of cases in Hispanics is
slower than for white non-Hispanics and for black
non-Hispanics.
The foreign born account for a large fraction
of the new cases seen in the United States (71).
The model assumptions regarding the future
contribution of the foreign born to the U.S.
population are from the U.S. Bureau of the
Census projections; therefore, this component of
the population may be thought of as forming part
of the backdrop against which the model
projections are made. Departure from the
patterns of immigration projected by the Census
Bureau could cause two kinds of errors in model
projections. A surge of immigration from
countries with high rates of TB would soon be
followed by increases in TB cases and case rates
in the United States that would not be projected
by the model. A different effect would be seen as
a consequence of unexpected large increases in
immigrants. Regardless of the TB status of the
countries of origin, an increase in the number of
immigrants would be reflected first in an
artificial lowering of case rates because of the
increase in denominators, followed by a longer-
term slow increase in numbers of cases. The
model could not recognize these changes within
its current structure. These potential errors may
be avoided as additional structure better reflecting
immigrant status becomes incorporated into the155 Vol. 6, No. 2, March–April 2000 Emerging Infectious Diseases
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model so that unexpected influxes may be
modeled as exogenous inputs.
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